Straumann Holding

STMN.SW Large Cap

Healthcare · Medical Instruments & Supplies

Updated: Apr 5, 2026, 17:43 UTC

CHF 83.46

+0.26% today

52W: CHF 73.02 – CHF 115.00

52W Low: CHF 73.02 Position: 24.9% 52W High: CHF 115.00

🔗 Compare Brokers

Key Metrics

P/E Ratio

37.43x

Price-to-Earnings

Forward P/E

22.75x

Forward Price/Earnings

P/S Ratio

5.11x

Price-to-Sales

EV/EBITDA

17.64x

Enterprise Value/EBITDA

Div. Yield

120%

Annual dividend yield

Market Cap

$13.3B

Market Capitalization

Revenue Growth

2.2%

YoY Revenue Growth

Profit Margin

13.66%

Net profit margin

ROE

17.01%

Return on Equity

Beta

1.42

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

416,470

Average daily volume

Valuation Analysis

Signal

Overvalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

17 analysts

Avg. Price Target

CHF 105.82

+26.8% upside

Target Range

CHF 79.00 – CHF 123.00

About the Company

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions,

Sector: Healthcare Industry: Medical Instruments & Supplies Country: Switzerland Employees: 11,319 Exchange: EBS